Opioid Treatment Program

OUD is most effectively treated by combining FDA-approved medications (like methadone and buprenorphine) with behavioral therapies and support to manage opioid addiction, stabilize patients, reduce cravings, and prevent relapse.

• FDA-approved medication: Our care team will create a personalized medication assisted treatment (MAT) plan to help you recover from addiction. Safe, FDA-approved medicines help reduce cravings and withdrawal symptoms so you can focus on recovery.
• Medical care: Our medical team helps you manage withdrawal symptoms and cravings safely and comfortably. Each BrightView center has a team of medical providers, nurses, and support staff that work together to give you the care to support your journey.
• Behavioral health therapies: BrightView offers counseling to support healing and growth. Individual and group sessions offer a caring space to talk, build coping skills, and find strength in your recovery.

Our opioid addiction treatment program provides structured outpatient care with integrated services and a streamlined experience to support long-term recovery.

• Convenience: At most BrightView locations, patients can get their medication on-site from our OTP while they are already here for a medical or behavioral health visit. BrightView offers FDA-approved medications like buprenorphine (Suboxone®) and methadone, tailored to your needs.
• Reduced stigma: Everyone with a substance use disorder deserves a safe, supportive place for care. At BrightView, we treat you like a person. We treat addiction like a disease. Here you’ll find a welcoming environment where you can talk openly about your challenges and your progress without fear of judgment.
• Reduced barriers: Dedicated social support services remove key recovery barriers. Our team connects you with housing, employment, and legal aid, reducing stress so you can focus on recovery and build a strong foundation for the future.
• Medication access: BrightView provides more accurate medication dispensing, full prescription filling, and reliable access to SUD medications, reducing error rates, partial fills, and supply chain shortages that often require patients to make multiple retail pharmacy visits.
• Relapse prevention strategies: Patients receive tools and resources to navigate triggers and maintain long-term sobriety.